Unusually weak binding interactions in tetrazole-amidine complexes

Organic Letters

Volumn 8, Issue 7, 2006, Pages 1279-1282

  Tominey, Alan F ^a   Docherty, Paul H ^a   Rosair, Georgina M ^a   Quenardelle, Romain ^a   Kraft, Arno ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645943078     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol053072+     Document Type: Article

References (36)

1. a of the parent tetrazole is 4.6 (in 0.15 M aqueous KCl at 25 °C) and similar to that of acetic acid.
2. Herr, R. J. Bioorg. Med. Chem. 2002, 10, 3379-3393.
3. (a) Wexler, R. R.; Greenlee, W. J.; Irvin, J. D.; Goldberg, M. R.; Prendergast, K.; Smith, R. D.; Timmermans, P. B. M. W. M. J. Med. Chem. 1996, 39, 625-656.
4. (b) Naka, T.; Kubo, K. Curr. Pharm. Design 1999, 5, 453-472.
5. (a) Noda, K.; Saad, Y.; Kinoshita, A.; Boyle, T. P.; Graham, R. M.; Husain, A.; Karnik, S. S. J. Biol. Chem. 1995, 270, 2284-2289.
6. (b) Noda, K.; Saad, Y.; Karnik, S. S. J. Biol. Chem. 1995, 270, 28511-28514.
7. In this respect, it is interesting to note that the crystal structure of a tetrazole-containing inhibitor of HIV-1 integrase shows the tetrazolate group of the inhibitor hydrogen-bonded to two protonated lysines of the protein receptor. Goldgur, Y.; Craigie, R.; Cohen, G. H.; Fujiwara, T.; Yoshinaga, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 13040-13043.
8. (a) Yamano, Y.; Ohyama, K.; Kikyo, M.; Sano, T.; Nakagomi, Y.; Inoue, Y.; Nakamura, N.; Morishima, I.; Guo, D.-F.; Hamakubo, T.; Inagami, T. J. Biol. Chem. 1995, 270, 14024-14030.
9. (b) Vauquelin, G.; Fierens, F. L. P.; Gáborik, Z.; Minh, T. L.; De Backer, J.-P.; Hunyady, L.; Vanderheyden, P. M. L. J. Renin Angiotensin Aldosteron Syst. 2001, 2, S32-S36.
10. Flower, D. R. Biochim. Biophys. Acta 1999, 1422, 207-234.
11. 2α analogues: (a) Schuster, V. L.; Itoh, S.; Andrews, S. W.; Burk, R. M.; Chen, J.; Kedzie, K. M.; Gil, D. W.; Woodward, D. F. Mol. Pharmacol. 2000, 58, 1511-1516.
12. Tyrosine phosphatase inhibitors: (b) Liljebris, C.; Larsen, S. D.; Ogg, D.; Palazuk, B. J.; Bleasdale, J. E. J. Med. Chem. 2002, 45, 1785-1798.
13. And glutamate receptor antagonists: Frølund, B.; Greenwood, J. R.; Holm, M. M.; Egebjerg, J.; Madsen, U.; Nielsen, B.; Bräuner-Osborne, H.; Stensbøl, T. B.; Krogsgaard-Larsen. P. Bioorg. Med. Chem. 2005, 13, 5391-5398.
14. (a) Zablocki, J. A.; Miyano, M.; Rao, S. N.; Panzer-Knodle, S.; Nicholson, N.; Feigen, L. J. Med. Chem. 1992, 35, 4914-4917.
15. (b) Suvire, F.; Floridia, R.; Giannini, F.; Rodriguez, A.; Enriz, R.; Jauregui, E. Molecules 2000, 5, 583-584.
16. (a) Alig, L.; Edenhoter, A.; Hadváry, P.; Hürzeler, M.; Knopp, D.; Müller, M.; Steiner, B.; Trzeciak, A.; Weller, T. J. Med. Chem. 1992, 35, 4393-4407.
17. (b) Ewing, W. R.; Becker, M. R.; Manetta, V. E.; Davis, R. S.; Pauls, H. W.; Mason, H.; Choi-Sledeski, Y. M.; Green, D.; Cha, D.; Spada, A. P.; Cheney, D. L.; Mason, J. S.; Maignan, S.; Guilloteau, J.-P.; Brown, K.; Colussi, D.; Bentley, R.; Bostwick, J.; Kasiewski, C. J.; Morgan, S. R.; Leadley, R. J.; Dunwiddie, C. T.; Perrone, M. H.; Chu, V. J. Med. Chem. 1999, 42, 3557-3571.
18. (c) Adler, M.; Davey, D. D.; Phillips, G. B.; Kim, S.-H.; Juncarik, J.; Rumennik, G.; Light, D. R.; Whitlow, M. Biochemistry 2000, 39, 12534-12542.
19. (a) Peters, L.; Fröhlich, R.; Boyd, A. S. F.; Kraft, A. J. Org. Chem. 2001, 66, 3291-3298.
20. (b) Kraft, A.; Peters, L.; Fröhlich, R. Acta Crystallogr. Sect. C 2002, 58, o272-o274.
21. Kraft, A.; Osterod, F.; Fröhlich, R. J. Org. Chem. 1999, 64, 6425-6433.
22. Biot, C.; Bauer, H.; Schirmer, R. H.; Davioud-Charvet, E. J. Med. Chem. 2004, 47, 5972-5983.
23. (a) Job, P. Ann. Chim. 1928, 9, 113-203.
24. (b) Blanda, M. T.; Horner, J. H.; Newcomb, M. J. Org. Chem. 1989, 54, 4626-4636.
25. The hyperbolic shape of the dilution curve was fitted to 1:1 host-guest complexation: (a) Schneider, H. J.; Kramer, R.; Simova, S.; Schneider, U. J. Am. Chem. Soc. 1988, 110, 6442-6448.
26. (b) Wilcox, C. S. In Frontiers in Supramolecular Chemistry and Photochemistry; Schneider, H.-J., Dürr, H., Eds.; VCH: Weinheim, 1991; pp 123-143.
27. (c) Macomber, R. S. J. Chem. Educ. 1992, 69, 375-378.
28. a tends to be lower if the carboxylate is substituted with a strongly electron-withdrawing residue: (a) Deng, Y.; Roberts, J. A.; Peng, S.-M.; Chang, C. K.; Nocera, D. G. Angew. Chem., Int. Ed. Engl. 1997, 36, 2124-2127.
29. (b) Papoutsakis, D.; Kirby, J. P.; Jackson, J. E.; Nocera, D. G. Chem. Eur. J. 1999, 5, 1474-1480.
30. (c) Kirby, J. P.; van Dantzig, N. A.; Chang, C. K.; Nocera, D. G. Tetrahedron Lett. 1995, 36, 3477-3480.
31. (d) Roberts, J. A.; Kirby, J. P.; Nocera, D. G. J. Am. Chem. Soc. 1995, 117, 8051-8052.
32. (e) Krechl, J.; Smrčková, S.; Kuthan, J. Collect. Czech. Chem. Commun. 1990, 50, 460-468.
33. For examples, see: (a) Lyakhov, A. S.; Voitekhovich, S. V.; Gaponik, P. N.; Ivashkevich, L. S. Acta Crystallogr. Sect. C 2003, 59, o22-o23.
34. (b) Alkorta, I.; Rozas, I.; Elguero, J. J. Chem. Soc., Perkin Trans. 2 1998, 2671-2675.
35. (c) Chertanova, L. F.; Struchkov, Y. T.; Sopin, V. F.; Kovalenko, V. I.; Timokhov, V. N.; Fronchek, E. V. Chem. Heterocycl. Compd. 1989, 655-657.
36. -5 M in DMSO at 25 °C (determined by electrical conductivity measurements) correlates well with the crystallographically observed short hydrogen bond in ammonium tetrazolates. Tsentovskii, V. M.; Bashkirtseva, V. E.; Evgen'ev, M. I.; Ivanova, Z. P.; Poplavskii, V. S.; Ostrovskii, V. A.; Koldobskii, G. I. Chem. Heterocycl. Compd. 1984, 1238-1240.